A Plus Biotechnology Co (ROCO:6918) COGS-to-Revenue : 0.28 (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co COGS-to-Revenue?

A Plus Biotechnology Co's Cost of Goods Sold for the three months ended in Mar. 2025 was NT$55.6 Mil. Its Revenue for the three months ended in Mar. 2025 was NT$196.4 Mil.

A Plus Biotechnology Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. A Plus Biotechnology Co's Gross Margin % for the three months ended in Mar. 2025 was 71.71%.

A Plus Biotechnology Co COGS-to-Revenue Historical Data

The historical data trend for A Plus Biotechnology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co COGS-to-Revenue Chart

A Plus Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.37

0.36

0.40

0.32

0.31

A Plus Biotechnology Co Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial								0.29	0.29	0.33	0.30	0.28

A Plus Biotechnology Co COGS-to-Revenue Calculation

A Plus Biotechnology Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	234.813	/	769.591
	=	0.31

A Plus Biotechnology Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	55.553	/	196.387
	=	0.28

A Plus Biotechnology Co (ROCO:6918) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

A Plus Biotechnology Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	55.553 / 196.387
	=	71.71 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

A Plus Biotechnology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN

Website

https://www.aplusbio.com

A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines